Market Compliance and Surveillance

The HPRA investigates, on the basis of risk to public and animal health, reports of suspected quality defects in both human and veterinary medicines and in their related active substances. We also co-ordinates any subsequent recall actions on the Irish market.

Our risk based sampling and analysis programme is focused on monitoring the quality and safety of medicinal products both on the Irish market and produced for export

The HPRA also monitors the content of advertisements for human medicinal products to ensure they accurate, not misleading and in line with approved product information.

Quality Defects and Recalls 

Sampling and Analysis 

Advertising of Medicines